324 related articles for article (PubMed ID: 8229741)
1. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
2. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
3. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
von Euler M; Seiger A; Holmberg L; Sundström E
Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
Wrathall JR; Teng YD; Choiniere D
Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
[TBL] [Abstract][Full Text] [Related]
5. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
6. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
7. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors mediate development, but not maintenance, of secondary allodynia evoked by first-degree burn in the rat.
Jones TL; Sorkin LS
J Pharmacol Exp Ther; 2004 Jul; 310(1):223-9. PubMed ID: 15007101
[TBL] [Abstract][Full Text] [Related]
8. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
9. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
[TBL] [Abstract][Full Text] [Related]
10. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn.
Haseneder R; Kratzer S; Kochs E; Mattusch C; Eder M; Rammes G
Anesthesiology; 2009 Dec; 111(6):1297-307. PubMed ID: 19934875
[TBL] [Abstract][Full Text] [Related]
11. [N-methyl-D-aspartate (NMDA) receptor and pain].
Yamamoto T
Masui; 1996 Nov; 45(11):1312-8. PubMed ID: 8953862
[TBL] [Abstract][Full Text] [Related]
12. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
Nishiyama T
Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
[TBL] [Abstract][Full Text] [Related]
13. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M
J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons.
Wang T; French ED
Synapse; 1993 Mar; 13(3):270-7. PubMed ID: 7684531
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
[TBL] [Abstract][Full Text] [Related]
16. New role for spinal Stargazin in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated pain sensitization after inflammation.
Tao F; Skinner J; Su Q; Johns RA
J Neurosci Res; 2006 Sep; 84(4):867-73. PubMed ID: 16791853
[TBL] [Abstract][Full Text] [Related]
17. Characterization of audiogenic-like seizures in naive rats evoked by activation of AMPA and NMDA receptors in the inferior colliculus.
Yasuda S; Ishida N; Higashiyama A; Morinobu S; Kato N
Exp Neurol; 2000 Aug; 164(2):396-406. PubMed ID: 10915578
[TBL] [Abstract][Full Text] [Related]
18. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
Mead AN; Stephens DN
J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
[TBL] [Abstract][Full Text] [Related]
19. Effects of intrathecal NMDA and AMPA receptors agonists or antagonists on antinociception of propofol.
Xu AJ; Duan SM; Zeng YM
Acta Pharmacol Sin; 2004 Jan; 25(1):9-14. PubMed ID: 14704116
[TBL] [Abstract][Full Text] [Related]
20. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
Nellgård B; Wieloch T
Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
